The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.
2015/17/N/NZ3/03737
Keywords
Descriptors
- NZ3_1: Biologia komórki
- NZ2_1: Genetyka molekularna
- NZ5_7: Leczenie chorób człowieka
Panel
NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution
Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk
Voivodeship: dolnośląskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 9 – announced on 2015-03-16
- Amount awarded
- 150 000 PLN
- Project start date
- 2016-01-26
- Project end date
- 2018-02-25
- Project duration
- 25 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.
- Authors:
- Alicja Pawlak, Ewa Ziolo, Anna Fiedorowicz, Klaudyna Fidyt, Leon Strzadala, Wojciech Kalas
- Academic press:
- BMC Cancer (year: 2016, volume: 1,28680555555556, pages: 46035), Publisher: BioMed Central
- Status:
- Published
- DOI:
- 10.1186/s12885-016-2925-6 – link to the publication